# Long Antagonist Protocol for IVF With Single Luteal Dose of Degarelix

> **NCT03240159** · PHASE3 · UNKNOWN · sponsor: **Assisting Nature** · enrollment: 120 (estimated)

## Conditions studied

- Pregnancy, Ovarian

## Interventions

- **DRUG:** Degarelix

## Key facts

- **NCT ID:** NCT03240159
- **Lead sponsor:** Assisting Nature
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02-15
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2020-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03240159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03240159, "Long Antagonist Protocol for IVF With Single Luteal Dose of Degarelix". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03240159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*